Skip to content
Screener

Revvity RVTY Stock-Based Comp

Stock-Based Comp at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$83M+10.7%
Danaher logo
DanaherDHR
$93M+2.2%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$17.63M-6.1%
WAT
Waters CorporationWAT
$25M+92.7%
Agilent Technologies logo
Agilent TechnologiesA
$32M+6.7%
Illumina logo
IlluminaILMN
$60M-17.8%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$12.83B+28.7%
Enterprise value$15.91B+28.6%
P/E53.5×+18.6×
P/S4.4×+0.9×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Revvity’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:07 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000031791-26-000019
Line itemThree Months Ended / April 5,2026Three Months Ended / March 30,2025
Loss (income) from discontinued operations, net of income taxes175(568)
Income from continuing operations40,89341,669
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Stock-based compensation8,7157,731
Restructuring and other costs10,6753,239
Depreciation and amortization105,05697,422
Change in fair value of contingent consideration(99)(625)
Amortization of deferred debt financing costs and accretion of discounts1,1391,102

Item 1.Unaudited Financial Statements

FAQ

What is Revvity's stock-based comp?
Revvity (RVTY) reported stock-based comp of $8.72M in Q1 2026.
How has Revvity's stock-based comp changed year-over-year?
Revvity's stock-based comp increased by 12.7% year-over-year, from $7.73M to $8.72M.
What is the long-term trend for Revvity's stock-based comp?
Over 3 years (2021 to 2024), Revvity's stock-based comp has grown at a 8.4% compound annual growth rate (CAGR), from $29.68M to $37.81M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Revvity's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude